promo_leaderboard Ad
‹ All stocks
HRMY

Harmony Biosciences Holdings

HRMY · NASDAQ · Healthcare
$32.96
▼ $0.80 (-2.37%)
$32.75 $33.25 $33.74 $34.24 $32.96 Nov 11 Nov 14 Nov 17
Day range
$32.87 – $34.01
Year range
$25.90 – $43.49
Open
$33.78
Previous close
$33.76
Market cap
$1.94B
Volume (24h)
$710.5K
Volume (52w)
$23.42M
Performance
7D
▼ -1.76%
1M
▼ -12.20%
3M
▼ -17.46%
6M
▲ 8.10%
1Y
▼ -3.03%
YTD
▼ -11.82%
3Y
▲ 18.69%
5Y
▼ -15.81%
All-time
▼ -10.94%
Key statistics
P/E ratio
10.91
EPS (TTM)
$3.02
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
58.7M
About Harmony Biosciences Holdings

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.

Visit website
Country: United States of America
More in Healthcare